Search research articles
Contact Us
Filters
Showing results (111-120 of 173) with videos related to
Page
of 18
Sort By:
Addiction Biology
|
August 21, 2020
Abrupt cessation of reboxetine along alcohol deprivation results in alcohol intake escalation after reinstatement of drinking
Antonio Ballesta, Francisco Alen, Laura Orio, et al.
International Journal of Molecular Sciences
|
October 14, 2023
Antidepressant Medication Does Not Contribute to the Elevated Circulating Concentrations of Acylethanolamides Found in Substance Use Disorder Patients
Jesús Herrera-Imbroda, María Flores-López, Nerea Requena-Ocaña, et al.
Frontiers in Psychiatry
|
March 2, 2018
Higher Impulsivity As a Distinctive Trait of Severe Cocaine Addiction among Individuals Treated for Cocaine or Alcohol Use Disorders
Nuria García-Marchena, David Ladrón de Guevara-Miranda, María Pedraz, et al.
Biomedicines
|
May 28, 2022
Vascular Endothelial Growth Factor as a Potential Biomarker of Neuroinflammation and Frontal Cognitive Impairment in Patients with Alcohol Use Disorder
Nerea Requena-Ocaña, María Flores-Lopez, Esther Papaseit, et al.
Addiction Biology
|
February 27, 2018
Lysophosphatidic acid-induced increase in adult hippocampal neurogenesis facilitates the forgetting of cocaine-contextual memory
David Ladrón de Guevara-Miranda, Román Darío Moreno-Fernández, Sara Gil-Rodríguez, et al.
The Biochemical Journal
|
October 20, 2010
Expression of the cannabinoid system in muscle: effects of a high-fat diet and CB1 receptor blockade
Ana Crespillo, Juan Suárez, Francisco J Bermúdez-Silva, et al.
Neuropharmacology
|
June 6, 2006
Antiobesity effects of the novel in vivo neutral cannabinoid receptor antagonist 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-3-hexyl-1H-1,2,4-triazole--LH 21
Francisco Javier Pavon, Ainhoa Bilbao, Laura Hernández-Folgado, et al.
Journal of Psychoactive Drugs
|
July 7, 2017
Differences in the Rates of Drug Polyconsumption and Psychiatric Comorbidity among Patients with Cocaine Use Disorders According to the Mental Health Service
P Araos, Esperanza Vergara-Moragues, Francisco González-Saiz, et al.
Neuropsychobiology
|
May 20, 2024
Dysregulation of Plasma Growth Factors and Chemokines in Cocaine Use Disorder: Implications for Dual Diagnosis with Schizophrenia and Antisocial Personality Disorder in an Exploratory Study
Sandra Torres-Galván, María Flores-López, Enrique Ochoa, et al.
Addiction Biology
|
November 28, 2017
Increased plasma oleoylethanolamide and palmitoleoylethanolamide levels correlate with inflammatory changes in alcohol binge drinkers: the case of HMGB1 in women
María Antón, Alicia Rodríguez-González, Inmaculada Concepción Rodríguez-Rojo, et al.
Page
of 18
Search research articles
Search
Showing results (111-120 of 173) with videos related to
Sort By:
Page
of 18
Addiction Biology
|
August 21, 2020
Abrupt cessation of reboxetine along alcohol deprivation results in alcohol intake escalation after reinstatement of drinking
Antonio Ballesta, Francisco Alen, Laura Orio, et al.
International Journal of Molecular Sciences
|
October 14, 2023
Antidepressant Medication Does Not Contribute to the Elevated Circulating Concentrations of Acylethanolamides Found in Substance Use Disorder Patients
Jesús Herrera-Imbroda, María Flores-López, Nerea Requena-Ocaña, et al.
Frontiers in Psychiatry
|
March 2, 2018
Higher Impulsivity As a Distinctive Trait of Severe Cocaine Addiction among Individuals Treated for Cocaine or Alcohol Use Disorders
Nuria García-Marchena, David Ladrón de Guevara-Miranda, María Pedraz, et al.
Biomedicines
|
May 28, 2022
Vascular Endothelial Growth Factor as a Potential Biomarker of Neuroinflammation and Frontal Cognitive Impairment in Patients with Alcohol Use Disorder
Nerea Requena-Ocaña, María Flores-Lopez, Esther Papaseit, et al.
Addiction Biology
|
February 27, 2018
Lysophosphatidic acid-induced increase in adult hippocampal neurogenesis facilitates the forgetting of cocaine-contextual memory
David Ladrón de Guevara-Miranda, Román Darío Moreno-Fernández, Sara Gil-Rodríguez, et al.
The Biochemical Journal
|
October 20, 2010
Expression of the cannabinoid system in muscle: effects of a high-fat diet and CB1 receptor blockade
Ana Crespillo, Juan Suárez, Francisco J Bermúdez-Silva, et al.
Neuropharmacology
|
June 6, 2006
Antiobesity effects of the novel in vivo neutral cannabinoid receptor antagonist 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-3-hexyl-1H-1,2,4-triazole--LH 21
Francisco Javier Pavon, Ainhoa Bilbao, Laura Hernández-Folgado, et al.
Journal of Psychoactive Drugs
|
July 7, 2017
Differences in the Rates of Drug Polyconsumption and Psychiatric Comorbidity among Patients with Cocaine Use Disorders According to the Mental Health Service
P Araos, Esperanza Vergara-Moragues, Francisco González-Saiz, et al.
Neuropsychobiology
|
May 20, 2024
Dysregulation of Plasma Growth Factors and Chemokines in Cocaine Use Disorder: Implications for Dual Diagnosis with Schizophrenia and Antisocial Personality Disorder in an Exploratory Study
Sandra Torres-Galván, María Flores-López, Enrique Ochoa, et al.
Addiction Biology
|
November 28, 2017
Increased plasma oleoylethanolamide and palmitoleoylethanolamide levels correlate with inflammatory changes in alcohol binge drinkers: the case of HMGB1 in women
María Antón, Alicia Rodríguez-González, Inmaculada Concepción Rodríguez-Rojo, et al.
Page
of 18